Canopus Biopharma, Inc. Canopus Biopharma, Inc.

Canopus Biopharma, Inc.

CBIA

Rank in Stocks #33534
Canopus Biopharma, Inc. engages in the acquisition of businesses. The company... Canopus Biopharma, Inc. engages in the acquisition of businesses. The company was founded on April 8, 1986 and is headquartered in Las Vegas, NV.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$455.07K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
EPS for Canopus Biopharma, Inc. (CBIA)
EPS as of May 2023 TTM: $-0.01
According to Canopus Biopharma, Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2022 the company had an EPS of $-0.01, a decrease compared to its 2021 EPS of 0.00.
EPS history for Canopus Biopharma, Inc. from 2013 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 11.00%
2022 $-0.01 0.00%
2021 0.00 -100.00%
2014 $-0.02 -16.06%
2013 $-0.02 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$1.69 -15,325.23%
US
$1.93 -17,494.59%
SE
$6.91 -62,388.29%
FR
$0.02 -275.68%
HK
$2.71 -24,512.61%
IT

Questions about Canopus Biopharma, Inc.'s earnings per share (EPS)

What is Canopus Biopharma, Inc.'s earnings per share (EPS)?

Canopus Biopharma, Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of May 2023.

What was Canopus Biopharma, Inc.'s earnings per share (EPS) in 2022?

In 2022, Canopus Biopharma, Inc.'s earnings per share (EPS) was $-0.01, compared with 0.00 in 2021.

How has Canopus Biopharma, Inc.'s earnings per share (EPS) changed since 2021?

From 2021 to 2022, Canopus Biopharma, Inc.'s earnings per share (EPS) was highest in 2021 (0.00) and lowest in 2022 ($-0.01).

How does Canopus Biopharma, Inc.'s earnings per share (EPS) compare with similar companies?

Canopus Biopharma, Inc.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.